This new Call marks an important step in a process which will result in the selection of six Expressions of Interest addressing future life sciences challenges for discussion with scientists and funding organisations at the second annual EuroBioForum, scheduled to take place on December 5-7 2007 in Lisbon, Portugal.
By bringing together key stakeholders in life sciences, EuroBioForum will set the scene for the future financing and implementation of new research programmes via public and/or private partnerships.
EuroBioForum 2007 follows on the success of the first annual EuroBioForum which took place in Helsinki on 14-15 December 2006.
That event had attracted over 150 participants from twenty five European countries, including representatives from national and intergovernmental research-funding organisations, leading research scientists, policy makers and representatives from the European Commission, foundations, industry and patient organisations.
Wouter Spek, the director of EuroBioFund, commented that “By seeking ideas for future research programmes from the key stakeholders in the area of life sciences, EuroBioFund aims to further develop the European Research Area”.
EuroBioFund, which was launched in June 2006, is focused on public or public/private consortia from the research, finance, industry, government and consumer/patient sectors that are aiming to develop and implement strategic research agendas. The coordinating body has three key objectives.
The first of these is to provide a platform for funding organisations and life science researchers to foster joint research initiatives through networking and brokerage.
The second goal is to help organise research communities and facilitate "bottom-up" Europe-wide research programs, via the newly-formed EuroBioGenerator.
Finally, the EuroBioFund is charged with shaping "a new funding way in Europe by helping to develop joint investments and funding of life sciences research," through the establishment of EuroBioAccess.
The ESF is an association of 75 member organisations devoted to scientific research in 30 European countries. Since its inception in 1974, it has coordinated a wide range of pan-European scientific initiatives.
The deadline for Expressions of Interest is 28 May 2007 17.00 CET. For further information see www.esf.org/eurobiofund/eoi or contact Dr. Wouter Spek at email@example.com or Dr. Fiona Kernan at firstname.lastname@example.org.
Thomas Lau | alfa
The balancing act: An enzyme that links endocytosis to membrane recycling
07.12.2016 | National Centre for Biological Sciences
Transforming plant cells from generalists to specialists
07.12.2016 | Duke University
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
07.12.2016 | Health and Medicine
07.12.2016 | Life Sciences
07.12.2016 | Health and Medicine